OrganoBiotech is a biotech startup established in 2021 from Dr. Boyang Zhang’s lab at McMaster University, Canada. Our mission is to transform drug development by integrating high-throughput, human-centric Organ-on-a-Chip models with the analytical power of machine learning. We provide a suite of tissue culture platforms and equipment that enable our users to effectively develop and apply preclinical 3D human tissue models for drug development.
Company Details
- Employees
- 4
- Founded
- -
- Address
- Mcmaster Innovation Park, 175 Longwood Rd S, Suite 204 (E212),canada
- Industry
- Medical And Diagnostic Laboratories
- NAICS
-
Medical and Diagnostic LaboratoriesMedical LaboratoriesDiagnostic Imaging Centers
- Website
- http://www.organo-biotech.com
- HQ
- Hamilton, ON
Organobiotech, Inc. Questions
Organobiotech, Inc.'s website is http://www.organo-biotech.com
Organobiotech, Inc.'s LinkedIn profile is https://ca.linkedin.com/company/organobiotech
Organobiotech, Inc. has
4 employees.
View email and phone details for 4
employees at Organobiotech, Inc..
Organobiotech, Inc.'s industry is
Medical and Diagnostic Laboratories
Organobiotech, Inc.'s top competitors are
Fendx Technologies Inc.,
Noa Therapeutics,
Notogen Inc.,
Amacathera,
Omniabio,
Quthero,
Stemcell Technologies,
Healthsign,
Voxcell Bioinnovation,
Allarta Life Science Inc..
Organobiotech, Inc.'s categories are Medical and Diagnostic Laboratories
Organobiotech, Inc.'s founding year is 2021
